SavvyMoney | $225,000,000 | (Oct 28, 2025)
Serval | $47,000,000 | (Oct 28, 2025)
Honey Health | $7,800,000 | (Oct 28, 2025) Certified by Founder
Lodge
Tribune Therapeutics
start up
Norway
- Oslo
- 27/03/2025
- Seed
- $39,883,965
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
- Industry Biotechnology Research
- Website https://www.tribunetx.com/
- LinkedIn https://www.linkedin.com/company/tribune-therapeutics/
Natural | $9,800,000 | (Oct 28, 2025)
PodPlay Technologies | $8,000,000 | (Oct 28, 2025)
Bridge | $5,100,000 | (Oct 28, 2025)
Seneca | $60,000,000 | (Oct 28, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)